2010至2020年破裂与未破裂动脉瘤治疗趋势:聚焦血流导向装置
该大样本横断面研究基于MARINER数据库分析2010至2020年美国18岁以上患者动脉瘤治疗趋势,共45,542例手术(夹闭14,491例、栓塞28,840例、血流导向2,211例)。美国南部手术量最大,大脑中动脉动脉瘤多采用夹闭,前交通和后交通动脉瘤多采用栓塞和血流导向。血流导向在未破裂动脉瘤中增长最快,2019至2020年破裂动脉瘤使用也显著增加。
要点
- 2010至2020年美国共45,542例动脉瘤手术,其中栓塞28,840例、夹闭14,491例、血流导向2,211例。
- 大脑中动脉动脉瘤多采用夹闭,前交通和后交通动脉瘤多采用栓塞和血流导向。
- 血流导向在未破裂动脉瘤中增长最快,2019至2020年破裂动脉瘤使用也显著增加。
核心结论
- 血流导向装置在未破裂和破裂动脉瘤治疗中均获得显著关注,未来适应证和使用无疑将进一步增长,但对其应用的热情应被不断涌现的安全性和有效性数据所调和。
研究设计与样本
- 大样本横断面研究,分析MARINER数据库中2010至2020年美国18岁及以上患者,采用χ2检验比较分类变量,P值<0.05为有统计学意义。
主要发现
- 2010至2020年美国共实施45,542例手术,其中夹闭14,491例、栓塞28,840例、血流导向2,211例。
- 美国南部在全部3种干预类型中手术量最大,中西部紧随其后。
- 大脑中动脉动脉瘤多采用夹闭,而栓塞和血流导向技术最常用于前交通和后交通动脉瘤。
- 血流导向在未破裂动脉瘤治疗中增长最快,2019至2020年破裂动脉瘤治疗中的使用也显著增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Flow diverters are a promising new tool in the neurosurgeon's arsenal for aneurysm management. We sought to quantify the trends of flow diversion in comparison to traditional endovascular coiling and surgical clip ligation techniques in the United States from 2010 to 2020 with an emphasis on aneurysm location and preferences in usage for ruptured versus unruptured aneurysms. METHODS: In this large cross-sectional study, patients aged 18 and older within the MARINER database were analyzed. Descriptive characteristics were calculated for all included patients. χ2 tests were used to compare categorical variables. P values < 0.05 were statistically significant. RESULTS: A total of 45,542 procedures were conducted in the United States from 2010 to 2020 (clipping: 14,491; coiling: 28,840; flow diversion: 2211). The Southern United States had the largest operative volume across all 3 intervention types, closely followed by the Midwest. Aneurysms of the middle cerebral artery were mostly clipped, whereas coiling and flow diversion techniques were most utilized for anterior communicating and posterior communicating artery aneurysms. Flow diversion is growing most rapidly in the treatment of unruptured aneurysms, though there were also significant increases in usage for ruptured aneurysm treatment from 2019 to 2020. CONCLUSIONS: Flow diverters have gained significant traction in the treatment for both unruptured and ruptured aneurysms. In the coming years, the indications and use of flow diversion will undoubtedly grow further, but excitement over their application should be tempered by the safety and efficacy data that continues to emerge.
引用
- Mirpuri P, Khalid SI, McGuire LS, et al. Trends in Ruptured and Unruptured Aneurysmal Treatment from 2010 to 2020: A Focus on Flow Diversion. World Neurosurg. 2023. PMID: 37385440. doi:10.1016/j.wneu.2023.06.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。